MoneyWorks4Me

The Sales for the quarter ended June 2025 of Rs. 1114.79 millions rose by 39.21% from Rs. 800.79 millions.Good  Net Profit growth of 42.62% reported above the corresponding previous quarter figure of Rs. 83.67 millions to Rs. 119.33 millioins.Operating Profit saw a handsome growth to 245.61 millions from 176.35 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1114.79 800.79 39.21 1114.79 800.79 39.21 3701.97 3071.72 20.52
Other Income 3.76 2.78 35.25 3.76 2.78 35.25 19.20 18.30 4.92
PBIDT 245.61 176.35 39.27 245.61 176.35 39.27 823.64 684.63 20.30
Interest 27.60 24.78 11.38 27.60 24.78 11.38 98.78 103.87 -4.90
PBDT 218.01 151.57 43.83 218.01 151.57 43.83 724.86 509.77 42.19
Depreciation 47.60 40.19 18.44 47.60 40.19 18.44 182.58 195.11 -6.42
PBT 170.41 111.38 53.00 170.41 111.38 53.00 542.28 314.66 72.34
TAX 51.08 27.71 84.34 51.08 27.71 84.34 143.38 74.83 91.61
Deferred Tax 7.49 -0.32 -2440.63 7.49 -0.32 -2440.63 -15.89 -4.37 263.62
PAT 119.33 83.67 42.62 119.33 83.67 42.62 398.90 239.83 66.33
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 22.03 22.02 0.04 22.03 22.02 0.05 22.25 22.29 -0.18
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..